Works matching IS 13562622 AND DT 2010 AND VI 16 AND IP 5
1
- Clinical Risk, 2010, v. 16, n. 5, p. 199, doi. 10.1258/cr.2010.hld009
- Article
2
- Clinical Risk, 2010, v. 16, n. 5, p. 198, doi. 10.1258/cr.2010.10a020
- Article
3
- Clinical Risk, 2010, v. 16, n. 5, p. 198, doi. 10.1258/cr.2010.10a019
- Article
4
- Clinical Risk, 2010, v. 16, n. 5, p. 195, doi. 10.1258/cr.2010.10a018
- Article
5
- Clinical Risk, 2010, v. 16, n. 5, p. 194, doi. 10.1258/cr.2010.10a017
- Article
6
- Clinical Risk, 2010, v. 16, n. 5, p. 192, doi. 10.1258/cr.2010.10a016
- Article
7
- Clinical Risk, 2010, v. 16, n. 5, p. 191, doi. 10.1258/cr.2010.10a015
- Article
8
- Clinical Risk, 2010, v. 16, n. 5, p. 190, doi. 10.1258/cr.2010.10a014
- Article
9
- Clinical Risk, 2010, v. 16, n. 5, p. 190, doi. 10.1258/cr.2010.10a011
- Article
10
- Clinical Risk, 2010, v. 16, n. 5, p. 185, doi. 10.1258/cr.2010.010034
- Article
12
- Clinical Risk, 2010, v. 16, n. 5, p. 176, doi. 10.1258/cr.2010.010022
- Article
13
- Clinical Risk, 2010, v. 16, n. 5, p. 169, doi. 10.1258/cr.2010.010009
- Article
14
- Clinical Risk, 2010, v. 16, n. 5, p. 176, doi. 10.1258/cr.2010.010022
- Article
15
- Clinical Risk, 2010, v. 16, n. 5, p. 173, doi. 10.1258/cr.2010.010043
- Wacogne, Ian;
- Diwakar, Vinod
- Article
16
- Clinical Risk, 2010, v. 16, n. 5, p. 169, doi. 10.1258/cr.2010.010009
- Article
17
- Clinical Risk, 2010, v. 16, n. 5, p. 161, doi. 10.1258/cr.2010.010037
- Gallagher, Sean;
- Knight, Charles;
- Wragg, Andrew
- Article